Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crysta...
FY 2025
Mar 31, 2026
Q4 2025
Q2 2025
Sep 30, 2025
Q1 2025
Apr 2, 2025
FY 2024